T Cell Receptors for Human Alpha Fetoprotein Therapy, Apr 15
Summary
The European Patent Office published application EP3622074A1 titled "HUMAN ALPHA FETOPROTEIN-SPECIFIC T CELL RECEPTORS AND USES THEREOF" on April 15, 2026. The application, filed by Augusta University Research Institute, Inc., covers T cell receptor constructs targeting human alpha fetoprotein for cancer therapy. Inventors include Yukai He, Wei Zhu, Esteban Celis, Yibing Peng, and Lan Wang, with IPC classifications spanning C07K 14/725, C12N 15/113, and A61K 39/00 across 38 designated EPC contracting states.
“HUMAN ALPHA FETOPROTEIN-SPECIFIC T CELL RECEPTORS AND USES THEREOF”
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 34 changes logged to date.
What changed
The European Patent Office published patent application EP3622074A1 for human alpha fetoprotein-specific T cell receptors and their therapeutic uses on April 15, 2026. The application names Augusta University Research Institute, Inc. as applicant and lists five inventors across therapeutic biotechnology. The filing covers immunological compositions and methods for treating alpha fetoprotein-expressing cancers.
Affected parties include biotechnology and pharmaceutical companies engaged in T cell receptor therapy development, immunotherapy research, and oncology treatment development. The published application provides public notice of the claimed intellectual property scope in the designated European Patent Convention states, allowing third parties to assess potential freedom-to-operate considerations.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HUMAN ALPHA FETOPROTEIN-SPECIFIC T CELL RECEPTORS AND USES THEREOF
Publication EP3622074A1 Kind: A1 Apr 15, 2026
Applicants
Augusta University Research Institute, Inc.
Inventors
HE, Yukai, ZHU, Wei, CELIS, Esteban, PENG, Yibing, WANG, Lan
IPC Classifications
C07K 14/725 20060101AFI20201207BHEP C12N 15/113 20100101ALI20201207BHEP A61K 39/00 20060101ALI20201207BHEP A61P 35/00 20060101ALI20201207BHEP C12N 5/00 20060101ALI20201207BHEP A61K 38/00 20060101ALN20201207BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.